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During the pre-erythrocytic asymptomatic phase of malarial infection, sporozoites develop
transiently inside less than 100 hepatocytes that subsequently release thousands of
merozoites. Killing of these hepatocytes by cytotoxic T cells (CTLs) confers protection
to subsequent malarial infection, suggesting that this bottleneck phase in the parasite life
cycle can be targeted by vaccination. During natural transmission, although some CTLs
are generated in the skin draining lymph nodes, they are unable to eliminate the parasite,
suggesting that the liver is important for the sporozoite to escape immune surveillance.
The contribution of the organ to this process is unclear. Based on the known ability of
several hepatic antigen-presenting cells (APCs) to induce primary activation of CD8 T cells
and tolerance, malarial antigens presented by both infected hepatocytes and/or hepatic
cross-presenting APCs should result in tolerance. However, our latest model predicts that
due to the low frequency of infected hepatocytes, some T cells recognizing sporozoite
epitopes with high affinity should differentiate into CTLs. In this review, we discuss two
possible models to explain why CTLs generated in the liver and skin draining lymph nodes
are unable to eliminate the parasite: (1) sporozoites harness the tolerogenic property of
the liver; (2) CTLs are not tolerized but fail to detect infected cells due to sparse infection
of hepatocytes and the very short liver stage. We propose that while malaria sporozoites
might use the ability of the liver to tolerize both naive and effector cells, they have also
developed strategies to decrease the probability of encounter between CTLs and infected
liver cells. Thus, we predict that to achieve protection, vaccination strategies should
aim to boost intrahepatic activation and/or increase the chance of encounter between
sporozoite-specific CTLs and infected hepatocytes.
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INTRODUCTION
Worldwide, infection bymalaria-causing parasites kills nearly one
million people every year (Murray et al., 2012), and is one of the
most important causes of morbidity globally. Human disease is
caused by the five species of the Plasmodium genus. Parasites are
introduced by the bite of femaleAnophelesemosquitoes, which act
as a primary host in the parasite life cycle. The remainder of the
cycle continues in the human host. In endemic areas, individuals
are repeatedly infected, and co-infections by different species are
common. Natural infection does not generally confer protection
and therefore the development of effective vaccines is critical.
As the mosquito probes for blood, the sporozoites contained
in the mosquito salivary glands are predominantly released into
the dermis. Most of the parasites reside in the skin for between 1
and 6 h, while 20% migrate via the lymph directly into the skin
Abbreviations: APC, Antigen Presenting Cell; CTL, Cytotoxic T Cell; KC, Kupffer
Cell; LSEC, Liver Sinusoidal Endothelial Cell; MHC, Major Histocompatibility
Complex; TCR, T cell Receptor; CSP, Circumsporozoite Protein; ICAM-1,
Intercellular Adhesion Molecule 1; LFA-1, Lymphocyte Function-Associated
Antigen 1; LN, Lymph Node; PBL, Peripheral Blood Lymphocytes; HSC, Hepatic
Stellate Cells; rAAV, Recombinant Adeno-Associated Virus; DC, Dendritic Cell.
draining lymph nodes (LNs) (Sidjanski and Vanderberg, 1997;
Amino et al., 2006) where they are thought to induce or mod-
ulate the subsequent anti-parasite immune response (Yamauchi
et al., 2007; Guilbride et al., 2012). It is thought that most of the
sporozoites fail to migrate to the LNs and are cleared at the site of
inoculation, while a small proportion randomly finds its way to
the nearest blood vessel (Sidjanski and Vanderberg, 1997). After
crossing the endothelial barrier, the sporozoites enter the circula-
tion to reach the liver (Mota et al., 2001; Ishino et al., 2004, 2005;
Frevert et al., 2005). This organ is critical for the next phase of the
parasite life cycle, the pre-erythrocytic stage.
The pre-erythrocytic asymptomatic cycle phase may represent
the Achilles heel of the parasite, as it is during this bottle-
neck phase that infected hepatocytes could be efficiently targeted
and eliminated by cytotoxic CD8 T cells (CTLs) (Lau et al.,
2014). CD8 T cells and the cytokines IFN-γ and TNF-α have
been reported as being critical for sterile protection against pre-
erythrocytic parasites inside hepatocytes in both animal models
and humans (Schofield et al., 1987; Weiss et al., 1988; Krzych
et al., 2000; Overstreet et al., 2008; Good and Doolan, 2010;
Obeid et al., 2013). Interestingly, the most promising and efficient
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vaccine candidates in human clinical trials are based on live genet-
ically attenuated whole parasites that infect the liver but do not
progress to the blood stage (Epstein and Richie, 2013). Thus, tar-
geting antigens expressed during the pre-erythrocytic cycle phase
holds great hope and promise for anti-malaria vaccination.
The liver is acknowledged as a site of primary T cell activation
that promotes tolerance rather than effective priming (Bertolino
et al., 2002; Benseler et al., 2007; Crispe, 2014). Although acti-
vation of protective effector T cells specific for one of the major
immunodominant sporozoite-derived antigen has been shown
to be restricted to skin draining LNs (Chakravarty et al., 2007;
Obeid et al., 2013), it is not clear to what extent the liver con-
tributes to the activation of T cells specific for malarial antigens
expressed by infected hepatocytes, or whether this activation gen-
erates effector T cells. This question is particularly relevant to
vaccination strategies that immunize recipients with irradiated
sporozoites that infect the liver but arrest their development in
hepatocytes without generating blood stage parasites. The high
number of irradiated sporozoites used in this type of immu-
nization is several-fold higher than during natural infection by
mosquitos, and is necessary to generate sufficient numbers of T
cells for protection.
The liver stage of the parasite is often referred to as a silent
phase during which the parasite goes under the immunological
radar. It is possible that during this phase, the parasite harnesses
the ability of the liver to induce tolerance to avoid being elimi-
nated, and thus establishes productive infection. Alternatively, it
is possible that CTLs generated in LNs, and potentially liver, fail to
detect the very few infected hepatocytes during the short period
of the liver phase. This is particularly a limiting factor in rodent
models of malaria as the pre-erythrocytic phase lasts for only 2
days. Both models could explain why this phase is asymptomatic,
and apparently immunologically silent.
In this review, we will discuss the likelihood that a T cell
response is elicited in the liver during the pre-erythrocytic phase,
and the predicted outcome arising from such intrahepatic activa-
tion. Our arguments support a model in which sporozoites have
developed strategies to induce tolerance but also reduce to a min-
imum the chances of encountering T cells by delaying efficient
elimination of infected hepatocytes.
SITES OF T CELL PRIMING DURING THE PRE-ERYTHROCYTIC
PHASE
Unless an individual has been previously infected with malaria
parasites, their immune repertoire is predominantly naïve with
regard to parasite-specific responses. Naïve T cells recircula-
tion is restricted to the blood and lymph. Via these routes,
these cells can also access secondary lymphoid tissues (spleen
and LNs). In LNs, naive T cells scan for foreign antigens pre-
sented by dendritic cells (DCs) in the form of peptide-MHC
(p:MHC) complexes. Primary T cell activation by DCs allows
blast formation, cytokine secretion, proliferation, and differ-
entiation into cells endowed with effector function and the
capacity for trans-endothelial migration and entry into tissue
parenchyma.
As the dermis is the site of inoculation and the first site exposed
to sporozoites (Figure 1), it is not surprising that, as assessed
by IFN-γ production, the first signs of T cell activation after
mouse immunization with irradiated sporozoites (via mosquito
bite or intradermal injection) were detected in the skin drain-
ing LNs at 48 h (Chakravarty et al., 2007). TCR transgenic T cells
specific for the immunodominant antigen, the circumsporozoite
protein (CSP), were activated only in these LNs, but effector T
cells secreting IFN-γ were not detected in spleen, liver, or liver-
draining LNs of the recipients at this time point (Chakravarty
et al., 2007). Using a subcutaneous immunization protocol and
CD81−/− mice that facilitate restriction of antigen presentation
to the skin draining LN rather than the liver, it has been shown
that T cell priming in the skin draining LN is sufficient to confer
protection (Obeid et al., 2013). Depletion of CD11c+ cells abro-
gated efficient CD8 T cell priming (Jung et al., 2002; Obeid et al.,
2013), supporting the model that DCs carrying the sporozoite-
derived antigen from the dermis migrated to the draining LNs,
where they induced intranodal priming of CSP-specific T cells.
Although there is strong evidence that the skin draining LNs
prime T cells specific for early pre-erythrocytic proteins such as
CSP, other sporozoite proteins are specifically expressed by hepa-
tocytes during the subsequent liver stage. Furthermore, although
CSP is an immunodominant antigen in Balb/c mice, it is not
immunogenic for CTLs in C57Bl/6 mice, and in most humans
naturally infected with malaria parasites (Gruner et al., 2007).
Evidence that CSP is not the only protein that contributes to pro-
tection includes the development of protective immunity in mice
tolerant for CSP that were immunized with irradiated sporozoites
(Kumar et al., 2006), and the occurrence of CSP-independent
sterile protection under chloroquine prophylaxis after immuniza-
tion with irradiated sporozoites (Gruner et al., 2007; Mauduit
et al., 2010). It is unlikely that the skin-draining LNs play any role
in priming CD8 T cells against these mid to late pre-erythrocytic
proteins expressed by hepatocytes.
A recent study (Lau et al., 2014) demonstrated that activated
TCR transgenic CD8 T cells specific for an unidentified antigen
expressed by both liver and blood stage parasites protected against
subsequent Plasmodium infection, indicating that targeting anti-
gens expressed by hepatocytes can lead to protective immunity.
The compartment in which priming occurs is not clear. The liver
draining LNs are the most likely site in which CD8 T cells can be
primed following cross-presentation of hepatocyte-derived pro-
teins by DCs. However, it is possible that proteins expressed by
hepatocytes induce T cell activation and priming in the liver
itself.
THE LIVER: A SITE OF PRIMARY ACTIVATION FOR CD8 T
CELLS
The liver is now recognized as an alternative site (and the only
non-lymphoid organ in the body) in which naive CD8 T cells
can be activated independently of lymphoid tissues (Bertolino
et al., 2001). First demonstrated for CD8 T cells, this remark-
able hepatic immunological property has recently been extended
to CD4 T cells (Tay et al., 2014b). Thus, in addition to the hep-
atic draining LNs, primary activation of T cells specific for mid to
late pre-erythrocytic proteins could potentially occur in the liver
itself. As proteins such as CSP are also expressed during the early
phase of liver infection, intrahepatic tolerance might not only
Frontiers in Microbiology | Microbial Immunology February 2015 | Volume 6 | Article 41 | 2
Bertolino and Bowen Malaria: a liver immunology perspective
FIGURE 1 | Sequence of events during the pre-erythrocytic phase of
malaria parasite infection leading to the presentation of sporozoite
antigens to CD8 T cells in several compartments. Some sporozoites
injected by the mosquito migrate via the lymph into the skin draining lymph
nodes (LNs). Migratory DCs or resident DCs capturing sporozoite proteins
activate naive CD8 T cells and promote the generation of CTLs. Other
sporozoites migrate via the blood to the liver where they are retained by
hepatic stellate cells (HSC) and glide. After binding to a Kupffer cell (KC), they
cross the liver sinusoidal endothelial cells (LSEC) barrier, traverse through
several hepatocytes (H), before entering one in which they establish a
parasitophorous vacuole. After a short period (2 days in mice for P. berghei/P.
yoelii or 7 days in humans for P. falciparum), each infected hepatocyte
releases thousands of merozoites that will subsequently infect red blood
cells. While traversing hepatocytes, sporozoites leave a trail of CSP and
possibly other proteins. Antigens shed by infected hepatocytes could also
potentially be presented in the liver draining LNs.
affect naive T cells undergoing primary activation in this organ,
but also alter the fate of anti-CSP effector T cells primed in skin
draining LNs.
The ability of the liver to support primary CD4 and CD8 T cell
activation is likely enabled by its unusual architecture and distinct
resident populations of antigen-presenting cells.
UNIQUE ARCHITECTURE OF THE LIVER
The liver receives up to 25% of the cardiac output. Thus, T
cells pass through this organ multiple times during their lives,
and have the opportunity to interact with hepatic cells located
in the sinusoids. The structure of the liver sinusoids is key to
understand its role in intrahepatic T cell retention. Liver sinu-
soids are narrow capillaries with an average diameter of 10μm, in
which blood flow is more intermittent and slower than in other
capillaries. This unusual pattern of blood flow is contributed
to by the narrow diameter of the sinusoids, the contraction of
contractile smooth muscle sphincters in the walls of hepatic arte-
rioles (Macsween and Scothorne, 1979; Macphee et al., 1995),
and intermittent obstruction of the lumen by KCs (McCuskey
and Reilly, 1993). This unique architecture favors interactions
between leukocytes and hepatic cells, and intrahepatic recruit-
ment of T cells recognizing their cognate antigen within this
organ. Selectin-dependent leucocyte rolling normally observed
in capillaries is not observed in liver sinusoids, and selectins
are not required for the recruitment of leucocytes to this organ
(Wong et al., 1997; Bowen et al., 2004). In contrast, TCR/p:MHC
complex interactions and those between the adhesion molecules
LFA-1 and ICAM-1 are important to the retention of lympho-
cytes, and these have been shown to play a critical role in
the recruitment of CD8 T cells to the liver (Bertolino et al.,
2005).
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POTENTIAL APCs IN THE LIVER SINUSOIDS
Several hepatic cell types have been shown to be able to acti-
vate naive CD8 T cells in vitro (reviewed in Bertolino et al.,
2002). It is now accepted that most liver APCs located in the
sinusoids are able to induce primary activation in vivo as long
as they can access circulating T cells and express or capture
antigen.
Hepatocytes are located behind the endothelial cell layer, and
are the principal cell type of the liver, comprising 75% of hepatic
cells. These very large polyhedral, mono or bi-nucleated cells con-
tain up to 16N DNA content, and synthesize and secrete a wide
variety of biologically crucial molecules. They alsometabolize and
excrete many endogenous and xenobiotic substances. Steady state
hepatocytes express MHC class I molecules (both classical and
monomorphic CD1 molecules), and ICAM-1; inflammation also
induces expression of MHC class II molecules, CD40L, and cos-
timulatory molecules such as CD80 and CD86 (Bertolino et al.,
1998; Holz et al., 2008). Since they normally lack MHC class II
expression, resting hepatocytes may therefore only act as APCs for
CD1d- and MHC class I-restricted T cells. Primary hepatocytes
have also been demonstrated to drive efficient activation and pro-
liferation of naïve TCR transgenic CD8 T cells in vitro, confirming
their role as efficient APCs (Bertolino et al., 1998).
Despite the widespread view that hepatocytes are in a con-
cealed location, express low levels of MHC class I, and therefore
cannot be “seen” by T cells, available data suggests that, despite
their sub-endothelial location, this cell population efficiently
interacts with circulating CD8 T cells, and functions as effective
APCs. In vivo interactions between hepatocytes and naïve CD8
T cells have been demonstrated or suggested in different animal
models including transgenic mice (Bertolino et al., 2001; Bowen
et al., 2004; Derkow et al., 2007), liver transplants (Klein and
Crispe, 2006a; Tay et al., 2013), and mice treated with recombi-
nant adeno-associated viral (rAAV) vectors (Wuensch et al., 2006,
2010; Tay et al., 2014a,b). Using electron microscopy, we have
shown that circulating T cells make direct contact with hepato-
cytes through cytoplasmic extensions penetrating the endothelial
fenestrations that perforate the LSECs (Warren et al., 2006).
Furthermore, in contrast to early data, this study also demon-
strated that interactions between T cells and liver parenchymal
cells are maximized by the polarized expression of molecules
required for primary T cell activation, MHC class I and ICAM-
1, on the perisinusoidal cell membrane of hepatocytes (Warren
et al., 2006).
Liver sinusoidal endothelial cells are efficient scavenger cells
strategically located in the sinusoids, and able to clear low-density
lipoprotein (LDL) and capture particulate antigens and immune
complexes circulating via the blood and deliver them to hepato-
cytes (Sorensen et al., 2012). This uptake is mediated by mannose
receptor, and has been shown to be more efficient than that medi-
ated by KC, suggesting that LSEC specialize in this function. LSEC
constitutively express both MHC class I and class II molecules,
low levels of CD86, as well as adhesion molecules including
ICAM-1, VCAM-1 and dendritic cell-specific intercellular adhe-
sion molecule 3-grabbing non-integrin (DC-SIGN). They have
been shown to activate both naïve CD4 and CD8 T cells in vitro
(Knolle et al., 1999) and in vivo (Limmer et al., 2000).
Kupffer cells (KC) are the major population of tissue
macrophages in the body, and are relatively heterogeneous
(Ikarashi et al., 2013). Although some cells with KC-like prop-
erties can be reconstituted from bone marrow after lethal irra-
diation, most KC are derived from the yolk sac early after birth
(Jakubzick et al., 2013). Intravital spinning disk and multipho-
ton microscopy experiments have demonstrated that KC are able
to efficiently capture pathogens circulating within the sinusoids,
such as Borrelia burgdorferi (Lee et al., 2010), and contribute
to the formation of hepatic granulomas in Leishmania donovani
(Beattie et al., 2010) and Mycobacterium bovis BCG (Egen et al.,
2008) infections. KCs express MHC class I and II molecules,
ICAM-1, CD86, CD80 and function as APCs for naïve CD8 T cells
and CD4 T cells in vitro (Bertolino et al., 2002; Ebrahimkhani
et al., 2011). In vivo, there is now data showing that liver bone
marrow-derived cells (which include both KC and DC) are able
to efficiently retain adoptively transferred naïve TCR transgenic
CD8 T cells in an antigen-specific manner. This retention leads to
the rapid activation of the T cells within the liver (Bowen et al.,
2002; Holz et al., 2012; Tay et al., 2014b).
Hepatic stellate cells (HSC), also known as Ito cells, are located
between LSEC and hepatocytes. Following liver damage and
regeneration, they secrete the extracellular matrix that is critical
for tissue repair. However, this process is also responsible for the
development of fibrosis. In a non-inflamed liver, these cells play
a role in regulating blood flow via constriction to modulate the
diameter of the sinusoids (Rockey, 2001). Cultured HSC express
MHC Class I and II, CD1d, and low levels of CD80 and CD86
(Vinas et al., 2003; Winau et al., 2007). Contact between HSC and
T cells has not been directly observed; however, it is likely that
they occur via LSEC fenestrations as demonstrated for hepato-
cytes (Warren et al., 2006). The role of these cells in intrahepatic
T cell activation is still controversial. However, a key study has
demonstrated that HSCs are also able to activate naïve CD8 T
cells within the liver (Winau et al., 2007). In contrast, a more
recent study suggested that HSC are poor T cell stimulators and
function more as regulatory bystanders by promoting Tregs and
suppressing Th17 differentiation (Ichikawa et al., 2011). These
variant results might be due to contaminants in HSC prepara-
tions or to phenotypic changes after culture (Vinas et al., 2003).
Thus, further in vivo data is required to clearly demonstrate the
role of HSC as APCs in the intact liver.
It is important to note that the liver also contains DCs and bil-
iary epithelial cells. However, these cell types are located within
the portal tracts, behind a non-fenestrated endothelial cell layer,
and there is no experimental evidence suggesting that they are
able to initiate intrahepatic primary T cell activation (Holz et al.,
2010b). In addition, hepatic DCs aremostly immature, suggesting
that, like most tissue DCs, these cells induce primary T cell acti-
vation in liver draining LNs following maturation and migration
triggered by inflammation.
CROSS-PRESENTATION IN THE LIVER
Antigen cross-presentation is a specialized function restricted
to a limited number of APCs. In lymphoid tissues, only some
DC subsets can perform this function. In the liver, besides
liver resident CD8+ DCs, cross-presentation has been clearly
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demonstrated for LSEC, but the role of other hepatic APCs
remains controversial.
The role of LSEC in cross-presenting antigen in vivo has been
demonstrated in a series of in vitro and in vivo studies by Knolle
and colleagues, clearly establishing these cells as the main cross-
presenting cells of the liver. Primary activation of CD8 T cells by
LSEC generally promotes tolerance (Limmer et al., 2000) via sev-
eral mechanisms, including decreased expression of CD80 and
CD86 molecules required for efficient priming by secretion of
the immunosuppressive molecules PGE2 and IL-10 (Knolle et al.,
1998), up-regulation of the inhibitory ligand PD-L1 (Diehl et al.,
2008), and interaction with DC leading to loss of IL-12, CD80
and CD86 expression (Schildberg et al., 2008). However, LSEC-
activated CD8 T cells appear to survive in vivo for prolonged
periods, and can be reactivated and rescued from deletion upon
secondary encounter with DC (Bottcher et al., 2013).
The role of KC in cross-presenting antigen in vivo and the
outcome of such activation are more controversial. In vitro, KC
have been shown to inhibit T cell activation by secreting IL-10
(Knolle et al., 1995), but these cells also increase their expres-
sion of MHC class II and their APC function upon TLR3 lig-
ation (Maemura et al., 2005; You et al., 2008). In vivo, CD8
T cell activation by KC leads to CD8 T cell apoptosis (Holz
et al., 2012), suggesting that these APCs induce tolerance in
the absence of inflammation. By comparing the ability of hep-
atocytes, LSEC, and KC to cross-present cell-associated antigen
in vitro, Ebrahimkhani and colleagues have recently shown that
LSEC are more efficient than KC in cross-presenting antigen
(Ebrahimkhani et al., 2011).
Although one study also suggests that HSC can cross-present
antigen (Winau et al., 2007) they have also been described as poor
APCs and tolerogenic (Eksteen et al., 2009). HSC also appear to
promote the expansion of FoxP3+ regulatory T cells (Jiang et al.,
2008; Ichikawa et al., 2011) due to their high expression levels of
retinoic acid and TGF-β (Schwabe et al., 2006).
The role of hepatocytes in cross-presentation remains con-
troversial: although some studies have shown that puri-
fied hepatocytes cross-present cell-associated antigen in vitro
(Ebrahimkhani et al., 2011), other studies (Limmer et al.,
2000; Bongfen et al., 2007; Cockburn et al., 2011) suggest the
opposite.
INTERACTION OF SPOROZOITES WITH LIVER APCs
After entering via the skin, sporozoites migrate to the liver where
they glide along the hepatic sinusoids (Figure 1). The various cell
populations located in the hepatic sinusoids are critical for the
malaria sporozoites to establish infection in the liver.
HSC proteoglycans protruding through the endothelial fenes-
tration into the sinusoidal lumen have been shown to be critical
to the initial retention of circulating sporozoites (Frevert et al.,
1993; Pradel et al., 2002). Real time intravital microscopy exper-
iments have revealed that following retention, some sporozoites
glide along the sinusoid till they interact with KC (Frevert et al.,
2005). These cells express chondroitin and heparan sulfate pro-
teoglycans that promote sporozoite arrest (Pradel et al., 2002).
The apical cell pole of the parasite then positions itself against KC
and after a pause, the sporozoite traverses the KC, pushes slowly
across the sinusoidal cell barrier, and reaches the space of Disse
(Figure 1) (Frevert et al., 2005). Whether the sporozoite enters
via LSEC fenestrations or through the gap separating two adja-
cent LSEC has not been resolved, but the results of a recent study
suggest that 25% of sporozoites can cross LSEC via the para-
cellular route (Tavares et al., 2013). Once in the space of Disse,
sporozoites seem to increase their velocity and migrate for many
minutes through several hepatocytes, before they eventually local-
ize to a final one (Frevert et al., 2005) in which they establish
a parasitophorous vacuole (Mota et al., 2001). Hepatocytes are
required for the parasite to change its form and multiply. After a
period of 7 days in humans for P. falciparum or 2 days in mice for
P. berghei/P. yoelii, each infected liver cell releases 10,000–30,000
merozoites that will subsequently infect red blood cells (Figure 1).
This classically marks the end of the silent pre-erythrocytic phase,
and the beginning of the symptomatic erythrocytic stage of
the infection (Kappe et al., 2003; Frevert, 2004; Heussler et al.,
2006).
The gateway model, based on observations made using real
time intravital microscopy, suggests that sporozoite migration
from the sinusoidal lumen into the space of Disse require KC
(Baer et al., 2007). Consistent with the critical role of KC, P. yoelii
infection of mutant CSF-1-deficient op/opmice, that possess 75%
less KC (and other macrophages), leads to an 80% decrease in
the number of infected hepatocytes (Baer et al., 2007). It is not
entirely clear why the parasite would require KC to cross the
endothelium, and take the risk of triggering innate immunity,
instead of directly crossing the endothelium. Interestingly, avian
and reptilian Plasmodium species invade and replicate in KC and
other macrophages instead of infecting hepatocytes. It has been
postulated that during evolution in mammalian hosts the parasite
has retained the ability to bind to KC, but gained the property of
infecting hepatocytes instead of KC (Baer et al., 2007). Electron
micrographs often show KC resting in the lumen of the sinu-
soids, anchored between two adjacent LSEC. For this reason, it
has been proposed that KC act as a portal for sporozoites to cross
the endothelial barrier and reach the parenchyma (Baer et al.,
2007).
A more recent study using intravital laser spinning-disk con-
focal microscopy has however demonstrated that, although the
majority (78%) of all sporozoite crossing events associated with
cell-traversal activity involve KC, 22% involve direct cell traver-
sal of the LSEC without involving a KC (Tavares et al., 2013).
KC are thus not an absolutely mandatory gateway for sporo-
zoite crossing of the hepatic sinusoidal barrier. Interestingly, this
study also provided evidence that live sporozoites deficient in cell
traversal activity were trapped and degraded in KC, while only
∼10% of control sporozoites (probably those that have exhausted
their CTL capacity or alternatively those that are already dead
before they arrive in the liver) displayed similar lasting inter-
actions with KC. Although live sporozoites endowed with cell
traversal ability are not trapped and killed by KC, they have
been reported to inactivate and eventually kill the traversed
macrophage resident cell (Klotz and Frevert, 2008). The authors
of this study speculated that the main purpose of sporozoite cell
traversal in the liver is to avoid parasite clearance (Tavares et al.,
2013).
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ROLE OF THE LIVER IN PRIMARY T CELL ACTIVATION
DURING THE PRE-ERYTHROCYTIC PHASE
Due to the very low number of hepatocytes infected during
natural transmission, and the short duration of the liver phase
(between 2 and 7 days depending on the host species and the
malaria parasite strain) (Overstreet et al., 2008), the role of the
liver in priming CD8 T cells during natural transmission has been
difficult to address. Some studies have suggested that the low dose
of immunogen transmitted via onemosquito inoculum is not suf-
ficient to induce a clonal burst sufficient to generate an effective
T cell response (Hafalla et al., 2002). In addition, Plasmodium
blood stage infection has been shown to inhibit the maturation
and the capacity of DCs to initiate immune responses and sup-
press protective CD8 T cell responses against the liver stage in vivo
(Ocana-Morgner et al., 2003). Although it does not necessarily
extrapolate to natural Plasmodium transmission, immunization
with high numbers of irradiated or genetically attenuated sporo-
zoites that are capable of infecting hepatocytes, but do not develop
in the liver, excludes any effect of blood stage parasites. This type
of immunization allows a better understanding of the liver contri-
bution to CD8 T cell priming and is critical in optimizing vaccine
strategies.
Experiments performed using CSP-specific transgenic T cells
adoptively transferred into mice immunized with irradiated or
non-irradiated sporozoites argued against any significant effec-
tive CD8 T cell activation in the liver and liver draining LNs
(Chakravarty et al., 2007). However, although this study excluded
any contribution of the liver in priming protective anti-CSP CD8
T cells after Plasmodium infection, it did not rule out a role for
the liver in T cell activation during malaria parasite infection
for 2 main reasons. Firstly, T cell activation in this study was
assessed by IFN-γ production at 48h instead of other functionally
independent markers of T cell activation at earlier time points.
Although a hallmark of efficient priming and effector CD8 T cell
function, IFN-γ is poorly expressed by hepatocyte-activated CD8
T cells (Holz et al., 2008, 2012). In addition, the majority of T
cells activated in the liver undergo rapid deletion, leading to tol-
erance (Holz et al., 2010a). Secondly, this study focused on CSP, a
protein expressed by sporozoites before they invade hepatocytes.
Expression of this protein decreases after invasion, while other
proteins more specific for the liver stage of the parasite start to
be expressed.
The role of the liver in priming T cells specific for mid to
late pre-erythrocytic proteins therefore remains to be addressed.
Genetically attenuated sporozoites, designed to have arrested
development at a late liver stage, induced larger and broader CD8
T cell responses compared to radiation attenuated sporozoite
or early-arresting genetically attenuated parasite immunizations
(Butler et al., 2011). They also promoted superior protection in
inbred and outbred mice (Butler et al., 2011), providing further
support for the idea that bona-fide liver stage antigens can prime
protective immune responses.
A recent study byMichael Bevan and colleagues illustrates why
this question is important for anti-malaria parasite vaccination.
By using high-throughput screening and irradiated or attenuated
sporozoites, these investigators identified a unique CTL response
against an epitope derived from the parasite ribosomal L3 antigen
(Murphy et al., 2013), a protein expressed during the liver-stage
and in erythrocytes. Surprisingly, these CTLs did not follow the
general pattern of anti-CSP CTL responses, as they could be
expanded by heterologous prime-boost regimens, but not by
multiple sporozoite immunizations. These findings illustrate that
CTL responses specific for liver-stage proteins might require dif-
ferent immunization strategies than those specific for antigens
expressed by the incoming parasite. Although this study did not
clarify themechanisms responsible for these distinct CTL patterns
or whether other liver-stage proteins generate similar patterns, it
is tempting to speculate that they are caused by different priming
conditions in the liver and LNs.
Several studies have shown that intravenous administration
of attenuated sporozoites is superior to other routes in confer-
ring protection (Spitalny and Nussenzw, 1972; Richards, 1977;
Chatterjee et al., 1999; Douradinha et al., 2007; Epstein et al.,
2011) As sporozoites traveling via the intravenous route reach
the liver, these experiments support a major contribution of
this organ in priming effector cells. A recent study reporting
the results of a clinical trial of an anti-malaria parasite vaccina-
tion on 80 volunteers, confirmed that intravenous administration
of purified irradiated sporozoites promoted protection, while
inoculation of the vaccine via the skin was suboptimally immuno-
genic and protective (Epstein et al., 2011). A high frequency
of sporozoite-specific IFN-γ–producing CD8 T cells in the liver
was shown to confer protection in mice (Epstein et al., 2011).
Although it does not demonstrate the direct role of hepatic cells
in priming effector T cells during natural transmission, this study
suggests that targeting the liver route of activation might promote
protection.
Presentation of liver-stage sporozoite proteins to antigen-
specific CD8 T cells can occur either directly by infected hepato-
cytes (direct MHC Class I presentation pathway), or indirectly by
APCs that capture extracellular sporozoite-derived proteins syn-
thesized by hepatocytes and present them in the context ofMHC I
molecules (cross-presentation pathway). These two pathways are
detailed below.
ROLE OF INFECTED HEPATOCYTES IN PRIMARY T CELL
ACTIVATION IN MALARIA
Although sporozoites interact with many liver cell types, experi-
ments using bone marrow chimeric mice have demonstrated that
radio-resistant cells (most likely to be infected hepatocytes) are
likely to be the main cells presenting antigens derived from irra-
diated sporozoites to effector CD8 T cells in the liver (Chakravarty
et al., 2007). Furthermore, it has been shown that while DCs
cross-present CSP via endosomes, presentation of CSP by hepato-
cytes requires expression of the protein in the cytosol rather than
in endosomes (Cockburn et al., 2011). CSP presentation by hep-
atocytes was independent of cross-presentation (Cockburn et al.,
2011). Collectively, these results provide strong evidence that hep-
atocytes are the main liver cells infected by irradiated sporozoites,
and able to present cytosolic sporozoite antigens to T cells via the
direct MHC class I presentation pathway.
Some evidence also suggests that replication-competent
malaria parasite-infected hepatocytes contribute to CD8 T cell
priming: (i) elimination of hepatic stage parasites abrogates
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protection generated by administration of irradiated sporozoites
(Scheller and Azad, 1995); and (ii) protection induced by live
sporozoites in mice treated with chloroquine was abrogated by
primaquine treatment that eliminates the parasite from hepato-
cytes (Belnoue et al., 2004).
Most studies investigating the early immune events in malaria
have used mice immunized with a large dose of irradiated sporo-
zoites, and have focused on the abundant CSP that covers the
surface of sporozoites. This protein has multiple functions in
several stages of the parasite life cycle. It is thought to be a mas-
ter regulator of the development of the pre-erythrocytic stages
(Singh et al., 2007), and inhibits KC immune defense (Usynin
et al., 2007). In infected hepatocytes, CSP traverses the mem-
brane of the parasitophorous vesicle, enters the cytoplasm, and
translocates to the nucleus where it downregulates expression of
the transcription activation factor NF-κB (Singh et al., 2007).
This inhibits host inflammatory immune functions, and pro-
motes the development of the liver stage parasite (Singh et al.,
2007). Paradoxically, by entering the cytoplasm, CSP exposes itself
to proteasomal degradation and processing by the MHC Class
I presentation pathway. CSP has been shown to be an immun-
odominant protective T cell antigen (Kumar et al., 2006). Mouse
primary hepatocytes have also been shown to be able to pro-
cess Plasmodium berghei CSP after live sporozoite infection, and
present CSP-derived peptides to specific CD8 T cells in vitro in a
proteasome-dependent manner (Bongfen et al., 2007). A recent
study (Ma et al., 2013) performed using human primary hepato-
cytes has also confirmed that the direct MHC class I presentation
pathway is not markedly affected by live P. berghei sporozoites:
mRNA expression levels of all major components of the MHC
class I processing and presentation machinery were not signifi-
cantly affected by parasite replication at 24 or 48 h post-infection,
while the levels of MHC class I expression were decreased only
by 10–20% at the surface of infected host cells as compared
to either uninfected or untreated controls. Furthermore, ectopic
expression of CSP did not interfere with basalMHC class I expres-
sion, or IFN-γ and TNF-α-induced upregulation of MHC class I
expression (Ma et al., 2013).
These results therefore imply that CSP translocation to the
cytoplasm increases the risk of recognition and elimination of
infected hepatocytes following presentation of CSP-peptides by
the classical MHC class I presentation pathway. More recently,
LISP-2, a protein specifically expressed by mid to late stage par-
asites, has also been shown to be exported to the cytosol from
the parasitophorous vacuole (Orito et al., 2013). If this protein is
immunogenic, it also have the potential to be an immune target.
It is thought that the important function of CSP in the par-
asite development justifies why the parasite exposes itself to the
immune system in such a way. An alternative view is that primary
activation by hepatocytes leads to tolerance, and therefore this is
a low risk strategy for the parasite. Expression of CSP and other
liver-stage specific proteins on liver cells might also be critical to
tolerize effector CD8 T cells primed in skin-draining LNs.
OUTCOME OF PRIMARY CD8 T CELL ACTIVATION BY HEPATOCYTES
Hepatocytes are not “professional” APCs as they do not express
known costimulatory molecules such as CD80 and CD86.
Although these cells are able to induce primary activation and
proliferation of CD8 T cells, it is expected that this activa-
tion would not be as efficient as priming induced by mature
DCs. Our initial in vitro work demonstrated that naive CD8
T cells co-cultured with antigen-expressing hepatocytes were
activated, proliferated, and started to acquire cytotoxic activ-
ity, but died prematurely by apoptosis (Bertolino et al., 1998,
1999), suggesting that hepatocytes promoted T cell deletion and
tolerance.
To investigate the fate of CD8 T cells activated by antigen-
expressing hepatocytes in vivo, we have used transgenic models
and rAAV vectors to restrict antigen or relevant p:MHC expres-
sion to these cells in vivo. Hepatocyte-activated T cells adoptively
transferred into mice expressing the cognate p:MHC complex on
all hepatocytes were deleted within the first 4 days post-activation,
without developing significant cytotoxic activity (Bertolino et al.,
2001; Bowen et al., 2004; Holz et al., 2008; Tay et al., 2014a),
suggesting that this activation induced tolerance. In these stud-
ies, most CD8 T cells were rapidly deleted within the first few
hours post-activation as a result of invading hepatocytes and sub-
sequent degradation inside lysosomal compartments (Benseler
et al., 2011). Invasion of a cell into another cell is known as
“emperipolesis” (Humble et al., 1956; Overholtzer and Brugge,
2008), and is observed in liver sections in autoimmune and viral
hepatitis (Dienes, 1989). To distinguish this process of CD8 T cell
deletion within hepatocytes from emperipolesis without destruc-
tion of the invading cell, we have termed this process “suicidal
emperipolesis” (Benseler et al., 2011).
Some T cells surviving suicidal emperipolesis proliferate,
but subsequently die as a result of primary activation in the
absence of costimulatory molecules. This “death by neglect”
has been shown to be associated with low expression of
cytokines and high expression of the pro-apoptotic molecule Bim
(Holz et al., 2008).
Although hepatocytes generally induce T cell tolerance in vivo,
recent studies have suggested that this is not always the case. In
some experimental systems, CD8 T cells activated by hepatocytes
survived and became full effector cells (Wuensch et al., 2006;
Klein and Crispe, 2006b; Derkow et al., 2007). Our results suggest
that generation of CTLs by hepatocytes requires high TCR affinity
interactions and low frequencies of antigen-expressing hepato-
cytes; in the absence of these requirements, CD8 T cell tolerance
ensues in response to hepatocyte expressed antigen (Tay et al.,
2014a).
In malaria parasite infection, the frequency of sporozoite-
infected hepatocytes is low. Our recent studies therefore predict
that infected hepatocytes should be able to prime at least some
high affinity sporozoite antigen-specific T cells and generate full
effector cells that contribute to the anti-malaria CTL pool.
ROLE OF CROSS-PRESENTING APCs IN THE ANTI-MALARIA
RESPONSE
Unless the parasite has developed strategies to inhibit this process,
it is very likely that following entry into hepatocytes, some anti-
gens are shed, captured, and cross-presented by other cell types in
lymphoid tissues and/or the liver (Figure 1).
Although liver DCs are not accessible to naive T cells and
do not therefore contribute to intrahepatic activation, it is likely
that these APCs play a major role in cross-presenting antigens
www.frontiersin.org February 2015 | Volume 6 | Article 41 | 7
Bertolino and Bowen Malaria: a liver immunology perspective
in the liver draining LNs. In studies of transgenic models and
using the rAAV system mentioned above, our results suggest that
cross-presentation of antigens expressed by hepatocytes leads to
efficient T cell priming, resulting in full effector function (Tay
et al., 2014a). We have postulated that antigen presentation in
lymphoid tissues is the main pathway facilitating the generation
of CTLs directed against liver pathogens (Bowen et al., 2004,
2005).
Until recently, the exact location of the liver-draining LNs in
mice had not been identified (Barbier et al., 2012). Although
likely, the contribution of these lymph nodes to CTL genera-
tion during natural malaria parasite infection has not been clearly
demonstrated. However, a recent study (Lau et al., 2014) in which
mice were intravenously injected with high numbers of irradiated
sporozoites demonstrated preferential malarial-antigen specific
CD8 T cell activation and proliferation in the 3 hepatic draining
LNs (Barbier et al., 2012). The number of intrahepatic CD11c+
cells has also been reported to increase in mice injected with
irradiated P. yoelii sporozoites or from live parasites inoculated
by infected mosquitoes (Leiriao et al., 2005b). These potential
APCs have been shown to contain intracellular hepatocyte pro-
teins, suggesting that debris of apoptotic hepatocytes were taken
up by liver DCs (or recruited circulating DCs or monocytes)
(Leiriao et al., 2005b). Whether these cells migrate to the drain-
ing LNs and cross-present sporozoite antigens to T cells has
not been investigated in this study. Another study (Jobe et al.,
2009) used irradiated sporozoites to demonstrate that conven-
tional CD8+ DC able to induce the differentiation of naïve CD8
T cells into CD44hiCD45RBloCD62Llo effector memory T cells
accumulated in the livers of sporozoite-immunized mice, sug-
gesting that this liver DC subset is involved in the induction of
liver-stage antigen-specific CD8 T cells.
It is important to emphasize that most of these studies have
used high numbers (5 × 104 to 1 × 106) of irradiated parasites
injected intravenously, or mice bitten by 50 mosquitoes, that
do not reflect natural transmission. Thus, although DCs might
capture and cross-present sporozoite proteins from infected hep-
atocytes in the liver and/or draining LN when high numbers of
sporozoites are administered, the role of DCs in cross-presenting
sporozoite antigens derived from hepatocytes in the liver draining
LNs during natural transmission requires further investigation.
The function and fate of anti-malaria T cells activated by
potential cross-presenting hepatic APCs is relatively unknown.
Experiments performed using radiation-induced bone marrow
chimeras (Chakravarty et al., 2007) excluded any role for bone
marrow–derived hematopoietic-lineage liver cells, such as blood-
derived DCs or monocyte-derived macrophages, in the presenta-
tion of irradiated and live sporozoite-derived antigens to effector
CD8 T cells, suggesting that these APCs did not present antigens
to T cells. It is important to note that, despite the conclu-
sions of the study, these experiments did not exclude a role for
KC, as a large proportion of these liver-resident macrophages
are radio-resistant (Kennedy and Abkowitz, 1997; Klein et al.,
2007). In addition, the role of radio-resistant LSEC and stel-
late cells has not been clarified. Thus, in the absence of further
experimental evidence, any discussion on this topic remains
speculative.
It is clear that the parasite avoids being detected by CTLs
primed in the skin draining LNs by changing expression of pro-
teins after settling in hepatocytes. Once in the liver, it is likely that
it uses other strategies to avoid being eliminated by CD8 T cells
specific for liver stage proteins.
COULD SPOROZOITES HARNESS THE TOLEROGENIC
PROPERTY OF THE LIVER TO SUBVERT INTRAHEPATIC
IMMUNITY AND PREVENT ELIMINATION OF INFECTED
CELLS?
The first model is that malaria sporozoites prevent the genera-
tion of efficient CTLs that would kill infected cells by inducing
tolerance (“subversion from within” model, see Figure 2). This
possibility is more relevant to infection by irradiated sporozoites
that do not induce long lasting responses and could be tolerized.
Many studies in the literature suggest that the liver can tolerize
effector T cells. In transplantation, an hepatic allograft can reverse
rejection of previously transplanted organs from the same donor
(Benseler et al., 2007), even when the liver was transplanted up
to 6 days after the initial transplant, indicating that the liver allo-
graft is able to induce tolerance in the recently activated T cell
compartment. More recently, we have shown that expression of
an allo-MHC class I molecule in most hepatocytes prevented the
rejection of skin grafts expressing this allo-MHCmolecule despite
prior sensitization of recipient mice (Cunningham et al., 2013).
Finally, analyses performed in transgenic mouse models indicated
that TCR transgenic T cells activated in the LNs of recipient mice
accumulated in the antigen-expressing liver, killed some hepato-
cytes, but never induced chronic liver damage, again suggesting
that these effector T cells were silenced (Holz et al., 2010b, 2012).
How does the liver tolerize effector T cells? The original “grave-
yard” model proposed by Crispe and colleagues (Huang et al.,
1994;Mehal et al., 1999) suggested that the liver was a disposal site
for T cells activated in lymphoid tissues. This was consistent with
several studies showing efficient intrahepatic retention of acti-
vated CD8 and CD4 T cells. The same group later proposed that
the liver actively killed effector T cells recognizing their antigen
within the liver. However, as this theory could not account for the
presence of effective immune responses in the liver under some
circumstances, and did not allow for the presence of high num-
bers of effector/memory T cells in this organ (Belz et al., 1998;
Keating et al., 2007), this concept was subsequently abandoned
(Crispe et al., 2006; Bertolino et al., 2007).
We have recently revisited this question by showing that the
frequency of antigen-expressing hepatocytes is critical in deter-
mining tolerogenic outcome. When at least 25% of hepatocytes
expressed antigen, effector T cells primed in lymphoid tissues
were eventually silenced, while below this threshold cytotoxic T
cells survived after clearing antigen-expressing hepatocytes (Tay
et al., 2014a). This might explain the outcome of tolerance in
transplantation and transgenic systems, where there is ubiquitous
expression of antigen within the liver, and detection of memory T
cells in some viral models (Belz et al., 1998; Keating et al., 2007).
The mechanisms by which the liver silences effector CD8 T
cells in the presence of high dose antigen is not entirely clear, and
molecules such as Galectin-1, TNFR, and FasL on hepatic cells
have been suggested to play a key role in this process (reviewed in
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FIGURE 2 | Potential antigen presenting cells during the
pre-erythrocytic phase of malaria parasite infection eliciting tolerance
or effective immune responses (CTLs). Presentation of sporozoite
antigens to CD8 T cells in the liver could occur either by hepatocytes or
cross-presenting hepatic cells (LSEC and maybe KC). Although activation
by all these cells should lead to tolerance, T cells recognizing sporozoite
antigens expressed by infected hepatocytes with high affinity might
differentiate into full effector cells. Malarial antigens can also be presented
in skin and liver draining LNs by cross-presenting DCs. This activation
should lead to efficient priming and CTLs. The fate of effector cells
generated in the liver and lymphoid tissues and re-encountering
tolerogenic APCs in the liver (red arrows) is unknown.
Holz et al., 2010b, 2012). Our results suggest that most effector T
cells surviving the early phases of activation expressed high levels
of the pro-apoptotic molecule Bim, and died by apoptosis. T cells
that survived this phase displayed poor CTL function, associated
with an exhausted phenotype, including expression of high levels
of the inhibitory molecule PD-1, as well as reduced TCR and CD3
expression (Holz et al., 2010b, 2012; Tay et al., 2014a), indicative
of prolonged antigen exposure and reduced T cell activity (Ferber
et al., 1994). It is also possible that suicidal emperipolesis plays
an important role in the clearance of effector T cells recognizing
their cognate antigen within the liver. This question is currently
under investigation in our laboratory.
The extremely low frequency of infected hepatocytes during
the pre-erythrocytic stage (even when a high number of irradiated
sporozoites is used for immunization) is far from the high antigen
dose promoting silencing of effector cells. Based on this argu-
ment, we predict that the few infected hepatocytes and potential
cross-presenting hepatic APCs should be killed by CTLs, rather
than inducing tolerance.
DO SPOROZOITES AVOID BEING DETECTED BY CTLs?
The alternative model to explain how malaria sporozoites use the
liver to avoid being eliminated by the immune system is to hide
in this large organ to minimize as much as possible the probabil-
ity of encountering CTLs (“hide-and-seek” model, see Figure 3).
This model would apply to both live and irradiated sporozoites.
From the parasite perspective, it might be efficiently achieved by
infecting the minimum number of hepatocytes and by spending
the shorter possible time in the host cell.
Using quantitative PCR assays, it has been estimated that a
mosquito bite inoculates between 0 and 1297 live sporozoites into
the skin, with a mean number of 123 and a median number of
18 (Medica and Sinnis, 2005). As some of these parasites remain
in the skin or migrate to the LNs, only a few will make it to the
liver (Sidjanski and Vanderberg, 1997; Jin et al., 2007). As a result,
an extremely low number of hepatocytes become infected by live
sporozoites. It is estimated that in mice, 1 in a million hepatocyte
is infected while in humans the frequency is even lower (one in a
billion) (Van Braeckel-Budimir and Harty, 2014).
It is not clear whether T cells specific for the liver-stage malaria
parasite efficiently find the very few infected hepatocytes during
the short period of time they reside in the liver. It is likely that
they do not. This is particularly true for naive T cells for pri-
mary activation, but it would also be difficult for effector T cells
to find their targets (secondary activation). As the liver is made
of hundreds of millions of hepatocytes, this is akin to finding a
needle in a haystack. Thus, the low number of infected hepato-
cytes combined with the short amount of time sporozoites reside
in the cell might be a strategy used by the parasite to avoid both
T cell priming in the liver and escape immune surveillance by
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FIGURE 3 | Different potential strategies used by sporozoites to evade
immune surveillance by CTLs according to the “hide and seek” model.
To avoid being eliminated by CTLs generated in the LNs or intrahepatically,
malaria sporozoites might have developed several strategies: (i) the very low
frequency of sporozoites lowers the probability of encountering CTLs; (ii) the
short time spent in the liver (2–7 days) gives CTLs a very short time to kill all
infected cells; (iii) infection of hepatocytes at a distance from the entry point
might divert the CTLs to the wrong area; (iv) the trail of CSP left in
non-infected hepatocytes during cell traversal by sporozoites might be used
as a decoy to “buy” some precious time for the sporozoites.
CTLs. This might explain the apparent lack of effective immune
response during the pre-erythrocytic stage and the lack of long
lasting protection induced by both live and irradiated sporozoites.
Consistent with this model, high numbers (105) of irradiated
sporozoites injected intravenously did not elicit a very signifi-
cant activation and proliferation of naive TCR transgenic CD8
T cells in the liver during the first 2 days in comparison to the
spleen and liver draining LNs, although these T cells recognized
an antigen expressed by hepatocytes (Lau et al., 2014). Effector
cells generated in lymphoid tissues recirculated, however, to the
liver at day 3 (Lau et al., 2014). These findings suggest that, in
vaccination protocols using high numbers of irradiated sporo-
zoites, most of the primary T cell activation occurs in lymphoid
tissues rather than the liver. Whether this also occurs during natu-
ral transmission (lower physiological numbers of live sporozoites
inoculated by mosquitos) requires, however, further demonstra-
tion. Regardless of whether they are generated in LNs or spleen, to
achieve protective immunity CTLs would need to detect and kill
all infected hepatocytes during the very short period of the pre-
erythrocytic phase (2–7 days). One can predict that the success of
this killing is likely to be critically dependent on the total number
of effectors.
Results obtained using mouse and human immunization pro-
tocols using both attenuated or live sporozoites suggest that this
assumption is correct. These protocols can only achieve protec-
tion by injecting 1000-fold or more sporozoites than occurs in
natural transmission and/or by boosting the number of CSP-
specific CD8 T cells (Overstreet et al., 2008). Immunization
experiments in mice have suggested that long-term protection
requires a remarkably strong CD8 T-cell response, representing
a substantial fraction of the total CD8 T-cell pool (Schofield et al.,
1987; Weiss et al., 1988; Romero et al., 1989; Schmidt et al.,
2008). Optimal CD8 T cell priming was associated with persis-
tence of CSP in both lymphoid tissues and livers of mice, and
was mediated by DCs or macrophages (Cockburn et al., 2010).
By investigating the CD8 T-cell immune response in Balb/c mice
immunized with DC loaded with the immunodominant CSP, fol-
lowed by a boost provided by Listeria monocytogenes expressing
CSP, Harty and colleagues have recently shown that stable long
term protection upon live sporozoite challenge required CSP-
specific CD8 T-cell frequencies exceeding a threshold of 1% of
total PBLs (Schmidt et al., 2008). This threshold depends on
the mouse MHC strain and Plasmodium species (Van Braeckel-
Budimir and Harty, 2014). However, it significantly exceeds
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frequencies of antigen-specific CD8 T cells required for plausible
protection against various viral and bacterial infections.
In addition to minimizing the probability of being recognized
by T cells whilst within host hepatocytes, it is tempting to spec-
ulate that the sporozoite has developed several strategies to gain
precious time and further decrease this probability. For rodent
malaria parasites (P. berghei and P. yoelii), the timing of T cell acti-
vation might be sufficient to avoid immune recognition by CTLs
activated in LNs: by the time CTLs leave the LNs and circulate to
the liver (2–3 days), merozoites would have been generated and
the liver phase would be over. The pre-erythrocytic phase of P. fal-
ciparum in humans is longer (7–9 days) and other strategiesmight
be used by the pathogen to evade or delay immune detection.
One of these potential strategies is to use a decoy to divert the T
cells to non-infected cells. When live sporozoites traverse through
several hepatocytes before establishing the parasitophorous vac-
uole in a selected host cell (Frevert et al., 2005), they disrupt
the plasma membrane of several other hepatocytes (Mota et al.,
2001). During this process, they leave a trail of CSP (and possi-
bly other proteins) in the cytosol of affected cells (Figures 1, 3).
It is not clear whether hepatocytes recover from this cell traversal.
Studies using high number of live parasites have detected many
necrotic hepatocytes and increases in serum ALT (Frevert et al.,
2005), suggesting that sporozoites cause hepatocellular injury.
Whether this is an experimental artifact due to the high number
of parasites, or whether it occurs during natural malaria transmis-
sion needs to be clarified. However, if some hepatocytes quickly
repair their perforated membranes, it is likely that the CSP con-
tained in the cytosol of non-infected cells will be processed by
the MHC class I presentation pathway and form p:MHC com-
plexes. Consistent with this, by using live P. berghei sporozoites
deficient for the SPECT protein that is essential for cell traver-
sal, Bongfen et al. (2007) have demonstrated that both infected
and traversed primary hepatocytes process and present CSP to
CD8 T cells. The processing and presentation pathway involved
the proteasome, antigen transport through a post-endoplasmic
reticulum compartment, and aspartic proteases (Bongfen et al.,
2007).
Non-infected hepatocytes presenting CSP might be used by
the sporozoite as a decoy strategy to divert CD8 T cells toward
non-infected hepatocytes. This tactic might delay the time for
T cell detection, and increase the chance of survival of infected
hepatocytes. Interestingly, some reports suggested that infected
hepatocytes become resistant to apoptosis (Leiriao et al., 2005a;
Van De Sand et al., 2005), conferring an additional selective
advantage to infected cells.
The reason why the sporozoite needs to traverse several hepa-
tocytes before settling in one cell located at a distant site from the
point of entry is also intriguing and could be an additional strat-
egy developed by the parasite to further reduce the risk of being
detected by T cells (Figure 3). Upon KC traversal, the abundant
CSP on the sporozoite surface has been shown to induce cyclic
AMP (cAMP) that inhibits the assembly of the NADPH oxidase
(Usynin et al., 2007). This blocks the generation of reactive oxy-
gen species, a potent macrophage defense mechanism required to
destroy parasites (Usynin et al., 2007). Although this prevents the
parasite from being eliminated by the macrophage defense system
while it crosses the endothelium, it is possible that the traversed
KC releases cytokines and chemokines able to attract immune
cells. This might explain why in addition to blocking the respira-
tory burst, viable sporozoites also generate an anti-inflammatory
cytokine secretion profile in KC (Klotz and Frevert, 2008). KC
exposed to infectious sporozoites down-modulated MHC class I,
secreted no IL-12p40, and had reduced antigen presenting func-
tion (Steers et al., 2005), suggesting that the sporozites minimize
the potential signals that KC might release to attract immune
cells. Interestingly, in contrast to KC from naive mice exposed to
infectious sporozoites, KC from irradiated sporozoite-immune-
challenged mice up-regulated class I and costimulatory molecules
and produced elevated IL-12p40 relative to naive KC. These KC
also exhibited augmented APC activity (Steers et al., 2005).
Settling in the first hepatocyte at the initial entry point would
be highly risky for the parasite, as CD8 T cells would rapidly
find and kill the infected cell located close to the signaling KC.
Traveling to a distant site might buy precious time for the parasite
while it differentiates at a distant location.
In summary, malaria sporozoites seem to have developed
several strategies to avoid killing of infected hepatocytes by
sporozoite-specific CTLs. These include changing expression of
proteins within the infected hepatocyte, infecting an organ where
primary activation of CD8 T cells is biased toward the induction
of tolerance, and developing several tactics to decrease the proba-
bility that infected hepatocytes encounter antigen-specific T cells.
These arguments support the view that the predominant limita-
tion for malaria-specific T cells is finding/eliminating all infected
hepatocytes during the short period of the hepatic cycle phase,
rather than overcoming tolerance in the liver.
Thus, although both malaria sporozoites and hepatotropic
viruses target the liver, these pathogens seem to use totally differ-
ent strategies to escape immune recognition. Instead of infecting
many hepatocytes in a short period of time and exploiting the
tolerogenic properties of the liver, malaria sporozoites infect very
few cells, and have developed additional strategies to decrease the
probability of being detected by CTLs. This model predicts that
to be effective, anti-malaria vaccination protocols should aim to
boost the number of CTLs to increase their probability of finding
and killing all infected hepatocytes.
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